Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valat

Showing results (261-270 of 361) with videos related to

Pageof 37
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|August 25, 2007
Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal--part IIIPh Hubert, J-J Nguyen-Huu, B Boulanger, et al.
Scientific Reports|October 11, 2018
An innovative flow cytometry method to screen human scFv-phages selected by in vivo phage-display in an animal model of atherosclerosisAudrey Hemadou, Jeanny Laroche-Traineau, Ségolène Antoine, et al.
International Journal of Molecular Sciences|June 2, 2021
A Nano-Emulsion Platform Functionalized with a Fully Human scFv-Fc Antibody for Atheroma Targeting: Towards a Theranostic Approach to AtherosclerosisSamuel Bonnet, Geoffrey Prévot, Stéphane Mornet, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|July 29, 2011
Aerosolized gemcitabine in patients with carcinoma of the lung: feasibility and safety studyEtienne Lemarie, Laurent Vecellio, Jose Hureaux, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 5, 2008
Harmonization of strategies for the validation of quantitative analytical procedures: a SFSTP proposal part IV. Examples of applicationPh Hubert, J-J Nguyen-Huu, B Boulanger, et al.
Journal of Endocrinological Investigation|July 1, 1996
Treatment with long acting repeatable bromocriptine (Parlodel-LAR*) in patients with macroprolactinomas: long-term study in 29 patientsS I Jamrozik, A P Bennet, A James-Deidier, et al.
The Journal of Rheumatology|February 1, 1997
Efficacy and safety of meloxicam in patients with rheumatoid arthritisE M Lemmel, W Bolten, R Burgos-Vargas, et al.
Bioconjugate Chemistry|January 12, 2016
Solid Lipid Nanoparticles for Image-Guided Therapy of AtherosclerosisKhalid Oumzil, Michael A Ramin, Cyril Lorenzato, et al.
International Journal of Molecular Sciences|September 28, 2024
Phenotypic, Metabolic, and Functional Characterization of Experimental Models of Foamy Macrophages: Toward Therapeutic Research in AtherosclerosisAmina Sarah Henni Mansour, Mathilde Ragues, Julien Brevier, et al.
The Journal of Clinical Endocrinology and Metabolism|March 28, 2008
Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophyM C Vantyghem, D Vincent-Desplanques, F Defrance-Faivre, et al.
Pageof 37

Showing results (261-270 of 361) with videos related to

Sort By:
Pageof 37
Journal of Pharmaceutical and Biomedical Analysis|August 25, 2007
Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal--part IIIPh Hubert, J-J Nguyen-Huu, B Boulanger, et al.
Scientific Reports|October 11, 2018
An innovative flow cytometry method to screen human scFv-phages selected by in vivo phage-display in an animal model of atherosclerosisAudrey Hemadou, Jeanny Laroche-Traineau, Ségolène Antoine, et al.
International Journal of Molecular Sciences|June 2, 2021
A Nano-Emulsion Platform Functionalized with a Fully Human scFv-Fc Antibody for Atheroma Targeting: Towards a Theranostic Approach to AtherosclerosisSamuel Bonnet, Geoffrey Prévot, Stéphane Mornet, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|July 29, 2011
Aerosolized gemcitabine in patients with carcinoma of the lung: feasibility and safety studyEtienne Lemarie, Laurent Vecellio, Jose Hureaux, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 5, 2008
Harmonization of strategies for the validation of quantitative analytical procedures: a SFSTP proposal part IV. Examples of applicationPh Hubert, J-J Nguyen-Huu, B Boulanger, et al.
Journal of Endocrinological Investigation|July 1, 1996
Treatment with long acting repeatable bromocriptine (Parlodel-LAR*) in patients with macroprolactinomas: long-term study in 29 patientsS I Jamrozik, A P Bennet, A James-Deidier, et al.
The Journal of Rheumatology|February 1, 1997
Efficacy and safety of meloxicam in patients with rheumatoid arthritisE M Lemmel, W Bolten, R Burgos-Vargas, et al.
Bioconjugate Chemistry|January 12, 2016
Solid Lipid Nanoparticles for Image-Guided Therapy of AtherosclerosisKhalid Oumzil, Michael A Ramin, Cyril Lorenzato, et al.
International Journal of Molecular Sciences|September 28, 2024
Phenotypic, Metabolic, and Functional Characterization of Experimental Models of Foamy Macrophages: Toward Therapeutic Research in AtherosclerosisAmina Sarah Henni Mansour, Mathilde Ragues, Julien Brevier, et al.
The Journal of Clinical Endocrinology and Metabolism|March 28, 2008
Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophyM C Vantyghem, D Vincent-Desplanques, F Defrance-Faivre, et al.
Pageof 37